Literature DB >> 16364297

Upregulation of RAGE and its ligands in proliferative retinal disease.

Sophia I Pachydaki1, Samir R Tari, Song Eun Lee, Wanchao Ma, Joseph J Tseng, Alexander A Sosunov, Guellue Cataldergirmen, Nikolaos Scarmeas, Casper Caspersen, Stanley Chang, William M Schiff, Ann Marie Schmidt, Gaetano R Barile.   

Abstract

We sought to study the presence of the receptor for advanced glycation endproducts (RAGE) and its ligands, advanced glycation endproducts (AGEs), S100/calgranulins and amphoterin (high mobility group box 1 protein; HMGB1), in the vitreous cavity and epiretinal membranes (ERMs) of eyes of patients with proliferative diabetic retinopathy (PDR) and proliferative vitreoretinopathy (PVR). Undiluted vitreous specimens were collected from 30 eyes of 30 patients undergoing pars plana vitrectomy for repair of retinal detachment (RD) secondary to PDR (n = 15) or PVR (n = 15). The vitreous samples obtained from 10 eyes undergoing macular hole repair were used as controls. Epiretinal membranes were obtained from eight eyes with PDR and from 10 eyes with PVR. The levels of AGEs in the vitreous were measured using ELISA. The vitreous levels of soluble RAGE (sRAGE), S100/calgranulins and amphoterin were measured using Western blot analyses. The localization of RAGE and its ligands in ERMs was determined with immunohistochemistry. The vitreous levels of sRAGE were significantly increased in both PDR and PVR (p < or = 0.05) compared to control vitreous. In both PDR and PVR, the vitreous levels of AGEs (p < or = 0.01), S100/calgranulins (p < or = 0.05), and amphoterin (p < or = 0.01) were also elevated compared to control eyes. Expression of RAGE was detected in six of eight ERMs from eyes with PDR and eight of 10 ERMs from eyes with PVR. Many cells expressing RAGE also expressed vimentin, suggesting a glial cell origin. Ligands for RAGE were also detected in ERMs, with AGEs detected in five eyes with PDR and eight eyes with PVR. Similarly, S100 and amphoterin ERM expression was observed in six eyes with PDR; these ligands were also expressed in ERMs from eyes with PVR (8 and 7 cases, respectively). We conclude that RAGE and its ligands are increased in the vitreous cavity of eyes with PDR and PVR and are present in ERMs of eyes with these proliferative retinal disorders. These findings suggest a role for the proinflammatory RAGE axis in the pathogenesis of proliferative retinal diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364297     DOI: 10.1016/j.exer.2005.09.022

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  31 in total

Review 1.  Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy.

Authors:  Jena J Steinle
Journal:  Cell Signal       Date:  2020-06-01       Impact factor: 4.315

Review 2.  Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.

Authors:  Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

3.  AGEs Promote Oxidative Stress and Induce Apoptosis in Retinal Pigmented Epithelium Cells RAGE-dependently.

Authors:  Xin-Ling Wang; Tao Yu; Qi-Chang Yan; Wei Wang; Nan Meng; Xue-Jiao Li; Ya-Hong Luo
Journal:  J Mol Neurosci       Date:  2015-02-15       Impact factor: 3.444

Review 4.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

5.  The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.

Authors:  Galina Dvoriantchikova; Eleut Hernandez; Jeff Grant; Andrea Rachelle C Santos; Huan Yang; Dmitry Ivanov
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

6.  Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.

Authors:  Makiko Katagiri; Jun Shoji; Noriko Inada; Satoshi Kato; Shigehiko Kitano; Yasuko Uchigata
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

7.  Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.

Authors:  Makiko Katagiri; Jun Shoji; Satoshi Kato; Shigehiko Kitano; Yasuko Uchigata
Journal:  Int Ophthalmol       Date:  2016-11-09       Impact factor: 2.031

8.  Cytokine expression and barrier disruption in human corneal epithelial cells induced by alarmin released from necrotic cells.

Authors:  Ken Fukuda; Waka Ishida; Yusaku Miura; Tatsuma Kishimoto; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2017-07-19       Impact factor: 2.447

9.  Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

Authors:  Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Yayoi Kurita-Nakamura; Takanori Matsui; Takafumi Yoshida; Tsutomu Imaizumi
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

10.  High-mobility group box 1 protein in endophthalmitis.

Authors:  Noboru Arimura; Yuya Ki-I; Teruto Hashiguchi; Taiji Sakamoto; Ikuro Maruyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-23       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.